Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
476
DELISTED
MRC Global
MRC
| $26.8M | 0.06% |
1,324,899
-2,161,734
| -62% | -$39.4M |
|
|
TLRD
477
DELISTED
Tailored Brands, Inc.
TLRD
| $26.7M | 0.06% |
1,045,328
+296,974
| +40% | +$5.74M |
|
|
ERF
478
DELISTED
Enerplus Corporation
ERF
| $26.7M | 0.06% |
2,814,323
-279,755
| -9% | -$2.22M |
|
479
Hancock Whitney
HWC
$6.01B
| $26.6M | 0.06% |
618,067
+596,324
| +2,743% | +$22.7M |
|
480
CALL
NXP Semiconductors
NXPI
$56.1B
| $26.5M | 0.06% |
270,000
+230,000
| +575% | +$22.9M |
|
481
Adient
ADNT
$1.46B
| $26.3M | 0.06% |
+449,383
| New | +$23.7M |
|
482
First American
FAF
$7.38B
| $26.3M | 0.06% |
718,178
-88,764
| -11% | -$3.4M |
|
483
CNO Financial Group
CNO
$5.02B
| $26.3M | 0.06% |
1,373,429
+608,940
| +80% | +$10.5M |
|
484
Global Payments
GPN
$25B
| $26.2M | 0.05% |
377,173
+34,375
| +10% | +$2.47M |
|
485
DuPont de Nemours
DD
$18.5B
| $26.1M | 0.05% |
179,995
+162,225
| +913% | +$22.6M |
|
|
JNS
486
DELISTED
Janus Capital Group Inc
JNS
| $26.1M | 0.05% |
1,963,442
+528,904
| +37% | +$7.27M |
|
|
CELG
487
CALL
DELISTED
Celgene Corp
CELG
| $26M | 0.05% |
225,000
-25,000
| -10% | -$2.78M |
|
488
Myriad Genetics
MYGN
$292M
| $26M | 0.05% |
1,560,080
-118,846
| -7% | -$2.15M |
|
|
ENDP
489
DELISTED
Endo International plc
ENDP
| $25.9M | 0.05% |
1,573,485
-255,868
| -14% | -$4.5M |
|
490
CDW
CDW
$16.6B
| $25.9M | 0.05% |
497,247
+443,763
| +830% | +$21.6M |
|
|
SCG
491
DELISTED
Scana
SCG
| $25.9M | 0.05% |
352,860
-565,036
| -62% | -$40.3M |
|
492
Visteon
VC
$2.72B
| $25.8M | 0.05% |
320,907
+247,104
| +335% | +$18.6M |
|
493
Donaldson
DCI
$10.7B
| $25.7M | 0.05% |
611,915
+171,041
| +39% | +$6.79M |
|
494
Tanger
SKT
$4.47B
| $25.7M | 0.05% |
+717,705
| New | +$25.3M |
|
|
STOR
495
DELISTED
STORE Capital Corporation
STOR
| $25.5M | 0.05% |
1,033,654
+50,853
| +5% | +$1.31M |
|
496
Silicon Motion
SIMO
$8.25B
| $25.4M | 0.05% |
599,037
+133,961
| +29% | +$6.11M |
|
|
PTLA
497
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $25.4M | 0.05% |
1,132,279
+616,523
| +120% | +$12M |
|
498
PVH
PVH
$3.55B
| $25.2M | 0.05% |
279,170
-458,983
| -62% | -$48.3M |
|
499
Alliant Energy
LNT
$17.7B
| $25.2M | 0.05% |
664,778
+619,703
| +1,375% | +$22.9M |
|
500
Ryder
R
$9.39B
| $25.1M | 0.05% |
337,235
+133,013
| +65% | +$9.8M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.